table of content
1 Introduction to Research & Analysis Reports
1.1 Anti-VEGF Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-VEGF Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-VEGF Medicine Overall Market Size
2.1 Global Anti-VEGF Medicine Market Size: 2022 VS 2030
2.2 Global Anti-VEGF Medicine Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Anti-VEGF Medicine Sales: 2018-2030
3 Company Landscape
3.1 Top Anti-VEGF Medicine Players in Global Market
3.2 Top Global Anti-VEGF Medicine Companies Ranked by Revenue
3.3 Global Anti-VEGF Medicine Revenue by Companies
3.4 Global Anti-VEGF Medicine Sales by Companies
3.5 Global Anti-VEGF Medicine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-VEGF Medicine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-VEGF Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-VEGF Medicine Players in Global Market
3.8.1 List of Global Tier 1 Anti-VEGF Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-VEGF Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-VEGF Medicine Market Size Markets, 2022 & 2030
4.1.2 Single Target (Ranibizumab, etc.)
4.1.3 Multiple Targets (Aflibercept, Conbercept, etc.)
4.2 By Type - Global Anti-VEGF Medicine Revenue & Forecasts
4.2.1 By Type - Global Anti-VEGF Medicine Revenue, 2018-2023
4.2.2 By Type - Global Anti-VEGF Medicine Revenue, 2024-2030
4.2.3 By Type - Global Anti-VEGF Medicine Revenue Market Share, 2018-2030
4.3 By Type - Global Anti-VEGF Medicine Sales & Forecasts
4.3.1 By Type - Global Anti-VEGF Medicine Sales, 2018-2023
4.3.2 By Type - Global Anti-VEGF Medicine Sales, 2024-2030
4.3.3 By Type - Global Anti-VEGF Medicine Sales Market Share, 2018-2030
4.4 By Type - Global Anti-VEGF Medicine Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-VEGF Medicine Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Eye Clinic
5.1.4 Other
5.2 By Application - Global Anti-VEGF Medicine Revenue & Forecasts
5.2.1 By Application - Global Anti-VEGF Medicine Revenue, 2018-2023
5.2.2 By Application - Global Anti-VEGF Medicine Revenue, 2024-2030
5.2.3 By Application - Global Anti-VEGF Medicine Revenue Market Share, 2018-2030
5.3 By Application - Global Anti-VEGF Medicine Sales & Forecasts
5.3.1 By Application - Global Anti-VEGF Medicine Sales, 2018-2023
5.3.2 By Application - Global Anti-VEGF Medicine Sales, 2024-2030
5.3.3 By Application - Global Anti-VEGF Medicine Sales Market Share, 2018-2030
5.4 By Application - Global Anti-VEGF Medicine Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Anti-VEGF Medicine Market Size, 2022 & 2030
6.2 By Region - Global Anti-VEGF Medicine Revenue & Forecasts
6.2.1 By Region - Global Anti-VEGF Medicine Revenue, 2018-2023
6.2.2 By Region - Global Anti-VEGF Medicine Revenue, 2024-2030
6.2.3 By Region - Global Anti-VEGF Medicine Revenue Market Share, 2018-2030
6.3 By Region - Global Anti-VEGF Medicine Sales & Forecasts
6.3.1 By Region - Global Anti-VEGF Medicine Sales, 2018-2023
6.3.2 By Region - Global Anti-VEGF Medicine Sales, 2024-2030
6.3.3 By Region - Global Anti-VEGF Medicine Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Anti-VEGF Medicine Revenue, 2018-2030
6.4.2 By Country - North America Anti-VEGF Medicine Sales, 2018-2030
6.4.3 US Anti-VEGF Medicine Market Size, 2018-2030
6.4.4 Canada Anti-VEGF Medicine Market Size, 2018-2030
6.4.5 Mexico Anti-VEGF Medicine Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Anti-VEGF Medicine Revenue, 2018-2030
6.5.2 By Country - Europe Anti-VEGF Medicine Sales, 2018-2030
6.5.3 Germany Anti-VEGF Medicine Market Size, 2018-2030
6.5.4 France Anti-VEGF Medicine Market Size, 2018-2030
6.5.5 U.K. Anti-VEGF Medicine Market Size, 2018-2030
6.5.6 Italy Anti-VEGF Medicine Market Size, 2018-2030
6.5.7 Russia Anti-VEGF Medicine Market Size, 2018-2030
6.5.8 Nordic Countries Anti-VEGF Medicine Market Size, 2018-2030
6.5.9 Benelux Anti-VEGF Medicine Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Anti-VEGF Medicine Revenue, 2018-2030
6.6.2 By Region - Asia Anti-VEGF Medicine Sales, 2018-2030
6.6.3 China Anti-VEGF Medicine Market Size, 2018-2030
6.6.4 Japan Anti-VEGF Medicine Market Size, 2018-2030
6.6.5 South Korea Anti-VEGF Medicine Market Size, 2018-2030
6.6.6 Southeast Asia Anti-VEGF Medicine Market Size, 2018-2030
6.6.7 India Anti-VEGF Medicine Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Anti-VEGF Medicine Revenue, 2018-2030
6.7.2 By Country - South America Anti-VEGF Medicine Sales, 2018-2030
6.7.3 Brazil Anti-VEGF Medicine Market Size, 2018-2030
6.7.4 Argentina Anti-VEGF Medicine Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-VEGF Medicine Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Anti-VEGF Medicine Sales, 2018-2030
6.8.3 Turkey Anti-VEGF Medicine Market Size, 2018-2030
6.8.4 Israel Anti-VEGF Medicine Market Size, 2018-2030
6.8.5 Saudi Arabia Anti-VEGF Medicine Market Size, 2018-2030
6.8.6 UAE Anti-VEGF Medicine Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Faricimab
7.1.1 Faricimab Company Summary
7.1.2 Faricimab Business Overview
7.1.3 Faricimab Anti-VEGF Medicine Major Product Offerings
7.1.4 Faricimab Anti-VEGF Medicine Sales and Revenue in Global (2018-2023)
7.1.5 Faricimab Key News & Latest Developments
7.2 Bayer (Regeneron)
7.2.1 Bayer (Regeneron) Company Summary
7.2.2 Bayer (Regeneron) Business Overview
7.2.3 Bayer (Regeneron) Anti-VEGF Medicine Major Product Offerings
7.2.4 Bayer (Regeneron) Anti-VEGF Medicine Sales and Revenue in Global (2018-2023)
7.2.5 Bayer (Regeneron) Key News & Latest Developments
7.3 Brolucizumab
7.3.1 Brolucizumab Company Summary
7.3.2 Brolucizumab Business Overview
7.3.3 Brolucizumab Anti-VEGF Medicine Major Product Offerings
7.3.4 Brolucizumab Anti-VEGF Medicine Sales and Revenue in Global (2018-2023)
7.3.5 Brolucizumab Key News & Latest Developments
7.4 Kanghong Pharmaceutical
7.4.1 Kanghong Pharmaceutical Company Summary
7.4.2 Kanghong Pharmaceutical Business Overview
7.4.3 Kanghong Pharmaceutical Anti-VEGF Medicine Major Product Offerings
7.4.4 Kanghong Pharmaceutical Anti-VEGF Medicine Sales and Revenue in Global (2018-2023)
7.4.5 Kanghong Pharmaceutical Key News & Latest Developments
7.5 Santen
7.5.1 Santen Company Summary
7.5.2 Santen Business Overview
7.5.3 Santen Anti-VEGF Medicine Major Product Offerings
7.5.4 Santen Anti-VEGF Medicine Sales and Revenue in Global (2018-2023)
7.5.5 Santen Key News & Latest Developments
8 Global Anti-VEGF Medicine Production Capacity, Analysis
8.1 Global Anti-VEGF Medicine Production Capacity, 2018-2030
8.2 Anti-VEGF Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-VEGF Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-VEGF Medicine Supply Chain Analysis
10.1 Anti-VEGF Medicine Industry Value Chain
10.2 Anti-VEGF Medicine Upstream Market
10.3 Anti-VEGF Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-VEGF Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
